Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1238 (MIR1238) is a small, non-coding RNA molecule belonging to the microRNA family, implicated in the regulation of gene expression by binding to complementary sequences in mRNAs and promoting their degradation or suppressing their translation. Like other microRNAs, MIR1238 functions as a post-transcriptional regulator, and may be involved in diverse biological processes such as cell differentiation, proliferation, and apoptosis, depending on its specific mRNA targets. Its biological and disease-specific roles have not been widely characterized in the literature; there is no evidence of MIR1238 serving as a clinical biomarker or drug-interaction partner at this time. If further specificity or data on MIR1238 itself is needed, targeted genomic or transcriptomic searches for "hsa-mir-1238" in disease association databases and experimental studies would be necessary. As of the information above, it is a canonical, functional member of the microRNA gene family.
Antisense inhibition (for antagomirs targeting microRNA 1238); Mimic-based restoration of function (for miRNA mimics); RNA interference (general miRNA mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 1238 (MIR1238).